open access

Vol 91, No 4 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-04-29
Get Citation

The role of biological markers in predicting infertility associated with non-obstructive endometriosis

Nicolae Gica, Anca Maria Panaitescu, George Iancu, Radu Botezatu, Gheorghe Peltecu, Corina Gica
DOI: 10.5603/GP.2020.0039
·
Pubmed: 32374018
·
Ginekol Pol 2020;91(4):189-192.

open access

Vol 91, No 4 (2020)
ORIGINAL PAPERS Gynecology
Published online: 2020-04-29

Abstract

Objectives: Our study evaluates if the use of biological markers can predict the infertility in women with non-obstructive
endometriosis.
Material and methods: Two prospective, non-randomised studies were conducted to identify if CA-125, IL-6 and IL-8 can be
used as predictive markers for infertility in women with non-obstructive endometriosis. Peripheral levels of CA-125, IL-6 and
IL-8 were measured before laparoscopy in all patients.
Results: We found a total number of 152 patients with non-obstructive endometriosis, we divided them in two groups: fertile
and infertile women. There was a statistically significant difference of the mean of CA-125 values between the two groups
(p = 0.00). The patients with infertility had a significantly higher IL-6 serum values than the fertile patients (p = 0.00). Regarding
the IL-8 serum values, there was no statistically significant difference between the two groups fertile vs infertile, (p = 0.06).
Conclusions: The elevated serum levels of CA-125 and IL-6 was associated with an increased probability of being diagnosed
with infertility. The IL-8 had no value in predicting infertility associated with non-obstructive endometriosis.

Abstract

Objectives: Our study evaluates if the use of biological markers can predict the infertility in women with non-obstructive
endometriosis.
Material and methods: Two prospective, non-randomised studies were conducted to identify if CA-125, IL-6 and IL-8 can be
used as predictive markers for infertility in women with non-obstructive endometriosis. Peripheral levels of CA-125, IL-6 and
IL-8 were measured before laparoscopy in all patients.
Results: We found a total number of 152 patients with non-obstructive endometriosis, we divided them in two groups: fertile
and infertile women. There was a statistically significant difference of the mean of CA-125 values between the two groups
(p = 0.00). The patients with infertility had a significantly higher IL-6 serum values than the fertile patients (p = 0.00). Regarding
the IL-8 serum values, there was no statistically significant difference between the two groups fertile vs infertile, (p = 0.06).
Conclusions: The elevated serum levels of CA-125 and IL-6 was associated with an increased probability of being diagnosed
with infertility. The IL-8 had no value in predicting infertility associated with non-obstructive endometriosis.

Get Citation

Keywords

CA-125; IL-6; IL-8; biological marker; non-obstructive endometriosis; prediction of infertility

About this article
Title

The role of biological markers in predicting infertility associated with non-obstructive endometriosis

Journal

Ginekologia Polska

Issue

Vol 91, No 4 (2020)

Pages

189-192

Published online

2020-04-29

DOI

10.5603/GP.2020.0039

Pubmed

32374018

Bibliographic record

Ginekol Pol 2020;91(4):189-192.

Keywords

CA-125
IL-6
IL-8
biological marker
non-obstructive endometriosis
prediction of infertility

Authors

Nicolae Gica
Anca Maria Panaitescu
George Iancu
Radu Botezatu
Gheorghe Peltecu
Corina Gica

References (14)
  1. Giudice L, Kao L. Endometriosis. The Lancet. 2004; 364(9447): 1789–1799.
  2. Fassbender A. Biomarkers of endometriosis. Fertility and Sterility. 2013; 99: 1135–1144.
  3. Eskenazi B, Warner M. Epidemiology of endometriosis. Obstetrics and Gynecology Clinics of North America. 1997; 24(2): 235–258.
  4. Fassbender A, Burney RO, O DF, et al. Update on Biomarkers for the Detection of Endometriosis. Biomed Res Int. 2015; 2015: 130854.
  5. Counseller V. Endometriosis. American Journal of Obstetrics and Gynecology. 1938; 36(5): 877–888.
  6. de Ziegler D, Pirtea P, Carbonnel M, et al. Implantation markers and endometriosis. Reprod Biomed Online. 2005; 11(4): 464–468.
  7. Carmona F, Chapron C, Martínez-Zamora MÁ, et al. Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6. J Reprod Immunol. 2012; 95(1-2): 80–95.
  8. Carp HJA, Selmi C, Shoenfeld Y. The autoimmune bases of infertility and pregnancy loss. J Autoimmun. 2012; 38(2-3): 266–274.
  9. May KE, Conduit-Hulbert SA, Villar J, et al. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010; 16(6): 1–24.
  10. Gupta S, Agarwal A, Sekhon L, et al. Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol. 2006; 58(6): 527–551.
  11. Othman EED, Hornung D, Salem HT, et al. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008; 137(2): 240–246.
  12. Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod. 2002; 17(2): 426–431.
  13. Ohata Y, Harada T, Miyakoda H, et al. Serum interleukin-8 levels are elevated in patients with ovarian endometrioma. Fertil Steril. 2008; 90(4): 994–999.
  14. Salmeri FM, Laganà AS, Sofo V, et al. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest. 2002; 54(2): 82–87.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl